Skip to main content
OpenTrials

Clinical trial condition

Myotonic Dystrophy

Explore clinical trials studying Myotonic Dystrophy. Study availability and eligibility vary by location and protocol.

107 public trials 36 recruiting studies
Refine in advanced search Browse all conditions

Myotonic Dystrophy trial results

Recruiting

Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1

NCT05481879

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +10 more
Locations
  • Stanford University Stanford, California, United States
  • University of Florida College of Medicine Gainesville, Florida, United States
  • Indiana University School of Medicine Indianapolis, Indiana, United States
  • University of Iowa Iowa City, Iowa, United States
View all 20 locations
View Trial Details
Recruiting

A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1

NCT06667453

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +10 more
Locations
  • University of Calgary Calgary, Alberta, Canada
  • Ottawa Hospital Research Institute (OHRI) Ottawa, Ontario, Canada
  • CIUSSS du Saguenay-Lac-Saint-Jean Chicoutimi, Quebec, Canada
  • Montreal Neurological Institute Montreal, Quebec, Canada
View Trial Details
Recruiting

Study of ATX-01 in Participants With DM1

NCT06300307

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +10 more
Locations
  • UCLA Los Angeles, California, United States
  • University of Florida Gainesville, Florida, United States
  • University of Iowa Health Care - Department of Neurology Iowa City, Iowa, United States
  • University of Kansas Medical Center, Department of Neurology Fairway, Kansas, United States
View Trial Details
Recruiting

The Efficacy and Safety of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2

NCT06523400

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +9 more
Locations
  • Laboratory for Muscle Diseases and Neuropathies Leuven, Belgium
  • Aarhus University Hospital Aarhus, Denmark
  • Ludug-Maximilians University München, Germany
  • Azienda Ospedaliera Universitaria Policlinico Tor Vergata Rome, Italy
View Trial Details
Recruiting

The Spanish National Registry for Myotonic Dystrophy Type 1

NCT07385443

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DM1, Genetic Diseases, Inborn, +14 more
Locations
  • Hospitals within the DM1 network Multiple Locations, Andalusia, Spain
  • Hospitals within the DM1 network Multiple Locations, Basque Country, Spain
  • Hospitals within the DM1 network Multiple Locations, Canary Islands, Spain
  • Hospitals within the DM1 network Multiple Locations, Cantabria, Spain
View Trial Details

Related conditions